Background: Recent but limited evidence suggests that nasal lavage with hypertonic saline may be useful as an adjunctive treatment modality in the management of pediatric allergic rhinitis. The aim of this study was to clarify whether nasal irrigation with hypertonic solution should be routinely recommended to children with seasonal grass pollen rhinoconjunctivitis. Methods: Fourty-four children with seasonal grass pollen rhinoconjunctivitis were recruited. Twenty-two patients were random ized to receive three-times daily nasal rinsing with hypertonic saline during the pollen season, which lasted 7 weeks. Twenty-two patients were allocated to receive no nasal irrigation and were used as controls. Twenty patients per group completed the study. A mean daily rhinoconjunctivitis score based on the presence of nasal discharge and obstruction as well as ocular symptoms as reddening and itching were calculated for each week of the pollen season. Patients were allowed to use oral antihistamines when required and the mean number of drugs taken per week was also calculated. Results: The mean weekly rhinoconjunctivitis score in the active group was reduced during the whole pollen period. This difference was statistically significant in week 6 and 7 of therapy. A markedly reduced intake of oral antihistamines was also observed in patients allocated to nasal rinsing, being statistically significant in 5 of the 7 weeks. No adverse effect was reported in the active group. Conclusions: This study supports the use of nasal rinsing with hypertonic saline in the pediatric patient with seasonal allergic rhinoconjunctivitis. This treatment proved to be tolerable, inexpensive and effective.

Keywords:
Children, Grass pollen, Hypertonic solution, Nasal rinsing, Rhinoconjunctivitis
1.
Manning SC, Wasserman RL, Silver R, Phillips DL: Results of endoscopic sinus surgery in pediatric patients with chronic sinusitis and asthma. Arch Otolaryngol Head Neck Surg 1994;120:1142–1145.
2.
Aukema AA, Fokkens WJ: Chronic rhinosinusitis: Management for optimal outcomes. Treat Respir Med 2004;3:97–105.
3.
Heatley DG, McConnell KE, Kille TL, Leverson GE: Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg 2001;125:44–48.
4.
Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R: Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: A randomized controlled trial. J Fam Pract 2002;51:1049–1055.
5.
Bachmann G, Hommel G, Michel O: Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol 2000;257:537–541.
6.
Parsons DS: Chronic rhinosinusitis: A medical or surgical disease? Pediatr Sinusitis 1996;29:1–9.
7.
Talbot AR, Herr TM, Parsons DS: Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 1997;107:500–503.
8.
Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PTP: Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996;153:1503–1509.
9.
Taccariello M, Parish A, Darby Y, Scadding G: Nasal douching as a valuable adjunct in the management of chronic sinusitis. Rhinology 1999;37:29–32.
10.
Shoseyov D, Bidi H, Shai P, Shoseyov N, Shazberg G, Hurvitz H: Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. J Allergy Clin Immunol 1998;101:602–605.
11.
Garavello W, Romagnoli M, Sordo L, Gaini RM, Di Berardino C, Angrisano A: Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: A randomized study. Pediatr Allergy Immunol 2003;14:140–143.
12.
Delafuente JC, Davis TA, Davis JA: Pharmacotherapy of allergic rhinitis. Clin Pharm 1989;8:474–485.
13.
Tomooka LT, Murphy C, Davidson TM: Clinical study and literature review of nasal irrigation. Laryngoscope 2000;110:1189–1193.
14.
Klimek L, Johannssen V, Hundorf I, Hommel G, Hörmann K: A nasal rinsing with isoosmotic Emser brine solution is able to reduce drug use in seasonal allergic rhinitis. Allergologie 2001;7:309–315.
15.
Georgitis JW: Nasal hyperthermia and simple irrigation for perennial rhinitis: Changes in inflammatory mediators. Chest 1994;106:1487–1492.
16.
Krayenbuhl MC, Hudspith BN, Brostoff J, Scadding GK, Guesdon JL, Latchman Y: Nasal histamine release following hyperosmolar and allergen challenge. Allergy 1989;44:25–29.
17.
Baraniuk JN, Ali M, Yuta A, Fang SY, Naranch K: Hypertonic saline nasal provocation stimulates nociceptive nerves, substance P release, and glandular mucous exocytosis in normal humans. Am J Respir Crit Care Med 1999;160:655–662.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.